News: Public Health

A redesigned version of the coronavirus spike protein called HexaPro might speed up vaccine production and yield a more effective immune response to SARS-CoV-2.

The COVID-19 vaccine was only possible because a group of scientists and their partners in industry had already invested years in laying the groundwork.

Undergraduates in public health, neuroscience and computer science found ways amidst the pandemic to help out their communities and fellow classmates.

The hunt for an effective treatment for COVID-19 has led researchers to find an improbable ally for their work: a llama named Winter.

The texaphyrin molecule is designed to be more easily absorbed by cancerous cells than healthy human cells, reducing the drug’s side effects.

Researchers from UT Austin and the National Institutes of Health have made a critical breakthrough toward developing a vaccine for COVID-19

Meet Corwin Zigler and his research on how changes in air pollution regulations impact people's health, and his decision to join UT Austin's Department of...

Last year, University of Texas at Austin alumnus Michael Young won the Nobel Prize in Physiology or Medicine for discovering the molecular mechanism behind circadian rhythms.

A new combination of existing drug reduces the size of cancerous tumors in mice much more effectively than current treatments.